Afuco™ Anti-Human IL12RB1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IL12RB1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that specifically bind to IL12Rβ1, the non-signal transducing chain of the heterodimeric IL12 receptor are used to treat pathological disorders that can be treated by inhibiting IFNγ production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-378CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IL12RB1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |